Streetbeat News

Stock Prices

AVAV

AeroVironment shares are trading lower after the company reported Q4 financial results and issued FY25 EPS guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:41 pm

ELAN

Elanco Animal Health shares are trading lower following updates to the expected FDA approval timelines for Zenrelia and Credelio Quattro.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:41 pm

CNXC

Concentrix shares are trading higher following better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:40 pm

TNXP

Tonix Pharmaceuticals Holding shares are trading lower after the company announced the pricing of an approximately $4 million public offering of 7,060,918 shares at $0.57 per share.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:38 pm

TNXP

Tonix Pharmaceuticals has announced a public offering of approximately $4 million, selling 7,060,918 shares at $0.57 per share.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:37 pm

BSFC

Blue Star Foods Corp. (NASDAQ: BSFC) has announced a 2024 revenue growth forecast of at least 65%, with an anticipated annual run-rate exceeding $20 million. The company is seeing accelerated revenue growth from both current and new opportunities.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:37 pm

NKE

NIKE, Inc. (NYSE:NKE) is set to release its Q4 earnings, with analysts expecting an EPS of 83 cents, up from 66 cents last year, and revenue of $12.85 billion. Oppenheimer upgraded Nike's rating and raised the price target to $120. Nike offers a 1.57% annual dividend yield, translating to 37 cents per share quarterly. To earn $500 monthly from dividends, an investment of approximately $381,319 is needed.

Portfolio Pulse from Avi Kapoor

June 27, 2024 | 12:36 pm

GANX

Gain Therapeutics presented data on their lead compound GT-02287 at the FENS Forum 2024, highlighting its potential in treating neurodegenerative diseases.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:36 pm

HIMS

Hims & Hers Health shares are trading lower following a short report issued by Hunterbrook.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:35 pm

GNPX

Genprex has issued a letter providing a 2024 update, highlighting multiple clinical development milestones and ongoing patient treatment in three lung cancer clinical trials.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:35 pm